Skip to content

Clinical usefulness of virtual ablation guided catheter ablation of atrial fibrillation: prospective randomized study II (Virtual rotor mapping and catheter ablation) “CUVIA-AF II”

Clinical usefulness of virtual ablation guided catheter ablation of atrial fibrillation: prospective randomized study II: Virtual rotor mapping and catheter ablation “CUVIA-AF II”

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003613
Enrollment
660
Registered
2019-03-12
Start date
2018-08-24
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : •Active Comparator: conventional group Group operating the atrial fibrillation by physician's personal experience, not by virtual simulation. Intervention: Procedure: physician's

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - legal age over 19 years old or capable of providing consent for the target according to national law - Patients undergoing atrial fibrillation electrode ceramic resection in accordance with treatment guidelines, or patients who need electrode ceramic resection again due to recurrence or recurrence after maze surgery - Patients who meet the HIRA's criteria for atrial fibrillation re-treatment - Patients who are free from adverse reactions, economic problems, and other anticoagulants

Exclusion criteria

Exclusion criteria: - Patients who are scheduled to receive atrial fibrillation, but do not agree with this study and do not want to register - Older patients over 81 years of age - The patient who have renal disease of eGFR5) - The patient have experienced ischemic cerebral infarction more 2 times - Atrial fibrillation patients accompanying structural heart disease with severe heart disease or hemodynamic effects - The patients who missed out to recording of 3D CT, echo and electrocardiography.

Design outcomes

Primary

MeasureTime frame
incidence of ischemic cerebral infarction;rate of hospitalization;recurrence rate of atrial fibrillation;mortality

Secondary

MeasureTime frame
Major complication associated with the procedure : complication of hemorrhagic and embolic;Procedure time and Radiofrequency ablation time

Countries

Korea, Republic of

Contacts

Public ContactWonmin Lee

Yonsei University Health System, Severance Hospital

min961023@yuhs.ac+82-2-2228-8528

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 13, 2026